Cellebrite
CLBT
164 hedge funds and large institutions have $1.55B invested in Cellebrite in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 72 increasing their positions, 45 reducing their positions, and 18 closing their positions.
236% more call options, than puts
Call options by funds: $12.5M | Put options by funds: $3.73M
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
60% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 45
57% more capital invested
Capital invested by funds: $990M → $1.55B (+$560M)
11% more funds holding
Funds holding: 148 → 164 (+16)
3.88% more ownership
Funds ownership: 40.35% → 44.24% (+3.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.1M |
| 2 |
PP
Pertento Partners
London,
United Kingdom
|
+$34.9M |
| 3 |
CPM
Crescent Park Management
East Palo Alto,
California
|
+$24.8M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$24.2M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$20.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$54.7M |
| 2 |
TWCM
True Wind Capital Management
San Francisco,
California
|
-$24.6M |
| 3 |
Morgan Stanley
New York
|
-$24M |
| 4 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$19.4M |
| 5 |
Goldman Sachs
New York
|
-$14.2M |
CLBT Hedge Fund Activity: Q3 2024 in Review
164 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q3 2024, worth a combined $1.55B — up 57% from $990M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CLBT positions and 18 closed out — a net gain of 16 holders — while 72 added to existing stakes and 45 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $48.1M. The largest seller was Clal Insurance, cutting an estimated $54.7M.
- 164 institutional investors held Cellebrite (CLBT) as of Q3 2024, up from 148 in Q2 2024.
- Funds reported $1.55B of Cellebrite stock for Q3 2024, up 57% quarter-over-quarter.
- 34 funds opened new Cellebrite positions in Q3 2024 and 18 closed out, a net change of +16 holders.
- The largest Cellebrite buyer in Q3 2024 was Fidelity Investments, an estimated $48.1M added.
- The largest Cellebrite seller in Q3 2024 was Clal Insurance, an estimated $54.7M sold.
Based on aggregated 13F filings for Q3 2024.